Aichi, Japan

Akinari Hinoki

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Hitachi, Ltd., Nagoya University. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akinari Hinoki: Innovator in Cancer Detection

Introduction

Akinari Hinoki is a notable inventor based in Aichi, Japan. He has made significant contributions to the field of medical technology, particularly in cancer detection. His innovative work focuses on improving diagnostic methods for neuroblastoma, a type of cancer that primarily affects children.

Latest Patents

Hinoki holds a patent for a "Method, kit, and apparatus for cancer detection using urinary tumor markers." This invention provides a method, an apparatus, and a kit for detecting neuroblastoma in a subject and monitoring the therapeutic effect on the neuroblastoma by measuring urinary tumor markers in a sample from the subject. This advancement has the potential to enhance early detection and treatment monitoring for patients.

Career Highlights

Throughout his career, Akinari Hinoki has worked with prominent organizations such as Hitachi, Ltd. and Nagoya University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Hinoki has collaborated with notable colleagues, including Hiroo Uchida and Minoru Sakairi. These partnerships have facilitated the development of innovative solutions in cancer detection and treatment.

Conclusion

Akinari Hinoki's contributions to cancer detection technology exemplify the impact of innovation in healthcare. His work continues to pave the way for advancements that can improve patient outcomes and enhance diagnostic accuracy.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…